|
業務類別
|
Biotechnology |
|
業務概覽
|
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis. |
| 公司地址
| 331 Oyster Point Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 481-6770 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pliantrx.com |
| 員工數量
| 171 |
| Dr. Keith Cummings, M.B.A.,M.D. |
Chief Financial Officer |
美元 484.50K |
23/04/2025 |
| Dr. Bernard Coulie, M.B.A.,M.D.,PhD |
Director, President and Chief Executive Officer |
美元 640.82K |
23/04/2025 |
| Ms. Lily Cheung |
Chief Human Resources Officer |
-- |
23/04/2025 |
| Ms. Minnie Kuo |
Chief Operating Officer |
-- |
16/12/2025 |
|
|
| Dr. John T. Curnutte, M.D.,PhD |
Independent Director |
23/04/2025 |
| Dr. Bernard Coulie, M.B.A.,M.D.,PhD |
Director, President and Chief Executive Officer |
23/04/2025 |
| Dr. Katharine Knobil, M.D. |
Independent Director |
23/04/2025 |
| Mr. Steven E. Krognes, M.B.A. |
Independent Director |
23/04/2025 |
| Mr. Thomas A. McCourt |
Independent Director |
23/04/2025 |
| Mr. Darren S. Cline, M.B.A. |
Independent Director |
23/04/2025 |
| Dr. Suzanne L. Bruhn, PhD |
Independent Director |
23/04/2025 |
| Ms. Gayle A. Crowell |
Independent Director |
23/04/2025 |
| Mr. David E.I. Pyott, M.A.,M.B.A. |
Independent Director |
23/04/2025 |
| Dr. Hoyoung Huh,M.D.,PhD |
Non-Executive Chairman of the Board and Lead Independent Director |
23/04/2025 |
|
|
|
|
